Endpoints News Jan 27, 2026 CMS picks Lilly’s Trulicity, Gilead's Biktarvy for third round of Medicare negotiations
Endpoints News Jan 23, 2026 Former FDA deputies land at Lilly, AbbVie; Italy's Angelini has a new CEO
Endpoints News Dec 22, 2025 Aktis Oncology files for IPO to fund Lilly-partnered radiopharma pipeline
Endpoints News Dec 18, 2025 Lilly’s orforglipron is the first oral obesity therapy to show its worth in the maintenance setting
Endpoints News Dec 11, 2025 Lilly’s triple agonist posts strongest weight loss data yet, unusual skin side effect also reported